Table 1.
Clinical and social outcome for first episode psychotic patients in three different treatment modalities: changes from baseline to year 2
| SPP | IT | TaU | p | |
|---|---|---|---|---|
| GAF symptoms | 4.60 (-0.93; 10.13) | 6.06 (-0.63; 12.75) | 0 | 0.1072 |
| GAF function | 4.04 (-0.60; 8.68) | 7.20 (2.46; 11.94) | 0 | 0.0086 |
| GAF total | 3.63 (-1.13; 8.39) | 6.42 (1.22; 11.62) | 0 | 0.0400 |
| PANSS positive symptoms | -1.27 (-2.79; 0.25) | -1.96 (-3.59; -0.32) | 0 | 0.0406 |
| PANSS negative symptoms | 1.73 (-0.46; 3.91) | -3.05 (-5.57; -0.54) | 0 | 0.0035 |
Results from generalized linear mixed model (odds ratio) or linear mixed model (parameter estimate) with 95% confidence interval, adjusted for baseline value.
SPP - supportive psychodynamic psychotherapy; IT - integrated treatment; TaU - treatment as usual; GAF v Global Assessment of Functioning;
PANSS - Positive and Negative Syndrome Scale